These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10454141)

  • 1. Expression of wild-type and V210I mutant prion protein in human neuroblastoma cells.
    Vetrugno V; Malchow M; Liu Q; Marziali G; Battistini A; Pocchiari M
    Neurosci Lett; 1999 Jul; 270(1):41-4. PubMed ID: 10454141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant and infectious prion proteins display common biochemical properties in cultured cells.
    Lehmann S; Harris DA
    J Biol Chem; 1996 Jan; 271(3):1633-7. PubMed ID: 8576163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of transmissible spongiform encephalopathies: an introduction.
    Weissmann C
    J Toxicol Sci; 2002 May; 27(2):69-77. PubMed ID: 12058449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.
    Fischer M; Rülicke T; Raeber A; Sailer A; Moser M; Oesch B; Brandner S; Aguzzi A; Weissmann C
    EMBO J; 1996 Mar; 15(6):1255-64. PubMed ID: 8635458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
    Weissmann C
    FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
    Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
    PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic and familial CJD: classification and characterisation.
    Gambetti P; Kong Q; Zou W; Parchi P; Chen SG
    Br Med Bull; 2003; 66():213-39. PubMed ID: 14522861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
    Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
    PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell biological studies of the prion protein.
    Harris DA
    Curr Issues Mol Biol; 1999; 1(1-2):65-75. PubMed ID: 11475702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal properties of prion protein with insertional mutations in different cell types.
    Priola SA; Chesebro B
    J Biol Chem; 1998 May; 273(19):11980-5. PubMed ID: 9565627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper stimulates endocytosis of the prion protein.
    Pauly PC; Harris DA
    J Biol Chem; 1998 Dec; 273(50):33107-10. PubMed ID: 9837873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of donor genotype in RT-QuIC seeding activity of chronic wasting disease prions using human and bank vole substrates.
    Hwang S; Greenlee JJ; Nicholson EM
    PLoS One; 2020; 15(1):e0227487. PubMed ID: 31910440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.
    Crozet C; Lin YL; Mettling C; Mourton-Gilles C; Corbeau P; Lehmann S; Perrier V
    J Cell Sci; 2004 Nov; 117(Pt 23):5591-7. PubMed ID: 15494372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform.
    Lehmann S; Harris DA
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5610-4. PubMed ID: 8643624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular clues to pathogenesis in prion diseases.
    Laurent M; Johannin G
    Histol Histopathol; 1997 Apr; 12(2):583-94. PubMed ID: 9151145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms.
    Bossers A; Belt PBGM ; Raymond GJ; Caughey B; de Vries R; Smits MA
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4931-6. PubMed ID: 9144167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed computational analysis revealed mutation V210I on PrP induced conformational conversion on β2-α2 loop and α2-α3.
    Chandrasekaran P; Rajasekaran R
    Mol Biosyst; 2016 Oct; 12(10):3223-33. PubMed ID: 27523988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.